GAMMA Investing’s TriSalus Life Sciences TLSI Stock Holding History

GAMMA Investing’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$832	Buy	+193	New	+$914	﹤0.01%	4132
2026 Q2	–	Sell	-386	Closed	-$1.54K	–	4229
2026 Q1	$1.54K	Buy	386 +328	+566%	+$1.61K	﹤0.01%	3738
2025 Q4	$405	Buy	+58	New	+$325	﹤0.01%	3934

Other funds holding TLSI

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's TLSI Position: Q3 2026 in Review

GAMMA Investing opened a new position in TriSalus Life Sciences (TLSI) in Q3 2026: 193 shares worth $832. The stake represents ﹤0.01% of the portfolio and ranks #4132 among its holdings. This is a return to the name: GAMMA Investing previously reported a position in TLSI as recently as Q1 2026.

GAMMA Investing first reported a position in TLSI in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.54K in Q1 2026. 2 funds tracked by Wall St. Rank hold TLSI as of Q3 2026.

GAMMA Investing held 193 shares of TriSalus Life Sciences worth $832 as of Q3 2026.
TriSalus Life Sciences was a new GAMMA Investing position in Q3 2026.
TriSalus Life Sciences made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #4132 holding.
GAMMA Investing first reported a position in TriSalus Life Sciences in Q4 2025 and has held it in 3 quarters since.
GAMMA Investing's TriSalus Life Sciences position peaked at $1.54K in Q1 2026.
2 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.